A novel HPV16 E7-affitoxin for targeted therapy of HPV16-induced human cervical cancer

di Jiang, Pengfei, Wang, Lude, Hou, Bailong, Zhu, Jinshun, Zhou, Meng, Jiang, Jie, Wang, Ledan, Chen, Shao, Zhu, Shanli, Chen, Jun, Zhang, Lifang
Pubblicato in Theranostics (2018)

Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells

di Zhu, Jinshun, Kamara, Saidu, Cen, Danwei, Tang, Wanlin, Gu, Meiping, Ci, Xingyuan, Chen, Jun, Wang, Lude, Zhu, Shanli, Jiang, Pengfei, Chen, Shao, Xue, Xiangyang, Zhang, Lifang
Pubblicato in Cell Death Dis (2020)

Correction: Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells

di Zhu, Jinshun, Kamara, Saidu, Cen, Danwei, Tang, Wanlin, Gu, Meiping, Ci, Xingyuan, Chen, Jun, Wang, Lude, Zhu, Shanli, Jiang, Pengfei, Chen, Shao, Xue, Xiangyang, Zhang, Lifang
Pubblicato in Cell Death Dis (2020)

Novel Affibody Molecules Targeting the HPV16 E6 Oncoprotein Inhibited the Proliferation of Cervical Cancer Cells

di Zhu, Jinshun, Kamara, Saidu, Wang, Qi, Guo, Yanru, Li, Qingfeng, Wang, Linlin, Chen, Jingjing, Du, Qianqian, Du, Wangqi, Chen, Shao, Zhu, Shanli, Chen, Jun, Chu, Maoping, Zhang, Lifang
Pubblicato in Front Cell Dev Biol (2021)